Medinice SA (ICEP)

Currency in PLN
39.35
+1.35(+3.55%)
Closed·
Earnings results expected in 9 days
ICEP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
37.4040.40
52 wk Range
6.7450.00
Key Statistics
Bid/Ask
39.25 / 39.45
Prev. Close
38
Open
39.1
Day's Range
37.4-40.4
52 wk Range
6.74-50
Volume
48.79K
Average Volume (3m)
105.47K
1-Year Change
408.3979%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ICEP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock price movements are quite volatile

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Medinice S.A., a medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery. The company offers PacePress, a medical device to reduce the risk of complications following the implantation of cardiac electrotherapeutic devices, such as pacemakers or implantable cardioverter-defibrillators; CoolCryo, a cardiac cryoablation technology that uses liquid nitrogen as the cooling medium; and AtriClamp, a clip designed to close the left atrial appendage to minimize the risk of stroke in patients with atrial fibrillation. It also provides MiniMax, an ablation-mapping catheter used for detecting intracardiac electrophysiological signals, creating a 3D map of the heart, and performing intracardiac irrigated RF ablation to treat arrhythmias caused by abnormalities in the heart’s conduction system; and EP Bioptom, an electrode for endomyocardial biopsy using 3D mapping enabling simultaneous biopsy and creation of a three-dimensional heart map. The company was founded in 2012 and is headquartered in Warsaw, Poland.

Compare ICEP to Peers and Sector

Metrics to compare
ICEP
Peers
Sector
Relationship
P/E Ratio
9.4x3.7x−0.5x
PEG Ratio
0.010.060.00
Price/Book
4.5x2.4x2.6x
Price / LTM Sales
18,573.3x9.4x3.2x
Upside (Analyst Target)
-51.1%51.2%
Fair Value Upside
Unlock9.0%7.3%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Dec 03, 2025
EPS / Forecast
-0.11 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ICEP Income Statement

People Also Watch

289.40
KGH
-0.52%
686.00
CRI1
-2.56%
279.00
SNTP
-0.36%
41.20
DNP
+3.34%
64.20
PZU
-1.17%

FAQ

What Is the Medinice (ICEP) Stock Price Today?

The Medinice stock price today is 39.35 PLN.

What Stock Exchange Does Medinice Trade On?

Medinice is listed and trades on the Warsaw Stock Exchange.

What Is the Stock Symbol for Medinice?

The stock symbol for Medinice is "ICEP."

What Is the Medinice Market Cap?

As of today, Medinice market cap is 364.04M PLN.

What Is Medinice's Earnings Per Share (TTM)?

The Medinice EPS (TTM) is 4.95.

When Is the Next Medinice Earnings Date?

Medinice will release its next earnings report on Mar 18, 2026.

From a Technical Analysis Perspective, Is ICEP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Medinice Stock Split?

Medinice has split 0 times.

How Many Employees Does Medinice Have?

Medinice has 11 employees.

What is the current trading status of Medinice (ICEP)?

As of Mar 09, 2026, Medinice (ICEP) is trading at a price of 39.35 PLN, with a previous close of 38.00 PLN. The stock has fluctuated within a day range of 37.40 PLN to 40.40 PLN, while its 52-week range spans from 6.74 PLN to 50.00 PLN.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.